Pharmaceutical Product Development, a global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services, completed the acquisition of CRA Intermediate Holdings, a provider of research services to pharmaceutical and medical device industries. Financial terms were not disclosed.